// App-Quantinova.ai

2198 : Integrin v3-targeted lipase-labile docetaxel-prodrug micelles preferentially treat breast cancer bone metastases

Researchers

Presenter

  • Michael H. Ross

Principal Investigators

  • Alison K. Esser

  • Anne H. Schmieder

  • Grace Cui

  • Xiaoxia Yang

  • Xinming Su

  • Dipanjan Pan

  • Gregory M. Lanza

  • Katherine N. Weilbaecher

Medical Centers

  • Washington University School of Medicine, St. Louis, MO

  • University of Illinois, Urbana, IL.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Bone metastases

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Docetaxel

  • lipase

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved